Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.For licensed clinicians. Educational demonstration on synthetic data. Never enter real patient identifiers or protected health information: everything runs in your browser and nothing is sent or stored. Clinical decision support only; not FDA cleared; physician review is required.
CPE-006 · Safety
HG-SAFE-01: Possible pituitary mass effect
Possible pituitary mass effect. Evaluates severe or new headache OR visual field loss.
Active rulePriority 1Testosterone engine v1.0.0
Condition
- severe or new headache OR visual field loss
- low testosterone OR raised prolactin
What it reports
- Urgent assessment: possible pituitary mass effect
Diagnostic boundary
- Routine outpatient pathway is not appropriate.
Evidence
- EV-ES-PRL-2011Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96(2):273-288.Supports: Causes of raised prolactin, including drugs and macroprolactin; when to image the pituitary
Cases where this rule fires
Open a case to see this rule fire with real inputs, then change the values until it stops.
Try Biod in your practice
The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.